Traditional Chinese medicine composition for treating infantile eczema

Abstract

The invention relates to a traditional Chinese medicine composition for treating infantile eczema. The composition comprises the following medicinal materials in parts by weight: 5-10 parts of radix sophorae flavescentis, 3-5 parts of amoorcorn tree bark, 5-10 parts of tamarix chinensis, 3-8 parts of fructus cnidii, 3-5 parts of ligusticum wallichii, 6-9 parts of herba schizonepetae, 8-12 parts of cortex dictamni, 3-6 parts of radix stemonae, 5-15 parts of chrysanthemum, 3-10 parts of cicada slough, 8-12 parts of fructus kochiae, 8-12 parts of folium eriobotryae, 8-12 parts of rhizoma atractylodis and 2-5 parts of liquorice. The composition has effects of clearing away heat, drying dampness, activating blood circulation, promoting subsidence of swelling, dispelling wind and arresting itching; the medicine property of the composition is mild; and the composition is hormone-free, non-irritating, non-greasy, and convenient to use, so as to be accepted by an infant with the infantile eczema and parents easily.

Description

technical field [0001] The invention relates to a medicine for treating eczema, in particular to a Chinese medicinal composition prepared from Chinese herbal medicines for treating infantile eczema. Background technique [0002] Eczema in infants and young children is a common clinical disease, commonly known as "tinea milk" and "ringworm of fetus", characterized by various types of itchy rash, erythema, papules, scales, lichenification and exudation; Suffering, lingering and difficult to heal, and easy to relapse, make children emotionally disturbed and affect sleep and diet, and secondary bacterial infection can occur, hindering normal growth and health. Because it is not easy to choose medicines for infants and young children, the current treatment of this disease generally adopts the prevention and treatment of external application, but clinically external medicines often contain glucocorticoids or histamine antiallergic drugs, which can easily lead to systemic or local ...

AI Technical Summary

Problems solved by technology

[0002] Eczema in infants and young children is a common clinical disease, commonly known as "tinea milk" and "ringworm of fetus", characterized by various types of itchy rash, erythema, papules, scales, lichenification and exudation; Suffering, lingering and difficult to heal, and easy to relapse, making children emotionally disturbed and affecting sleep and eating, and secondary bacterial infections can occur, hindering normal growth and health

Because it is not easy to choose medicines for infants and young children, the current treatment of this disease generally adopts the prevention and treatment of external application, but clinically external medicines often contain glucocorticoids or histamine antiallergic drugs, which can easily lead to systemic or local eczema in children. Adverse reactions cause parents' passive resistance and poor treatment effect. Therefore, inventing a green drug with no side effects has become a clinical problem to be solved urgently.